Manlangit, Jiana Mae A.

HRN: 23-30-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2023
AMPICILLIN 250MG (VIAL)
07/11/2023
07/17/2023
IV
185 Mg
Q6H
Neonatal Pneumonia
Waiting Final Action 
07/11/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
07/11/2023
07/17/2023
IV
20 Mg
OD
Neonatal Pneumonia
Waiting Final Action 
07/14/2023
CEFOTAXIME 500MG (VIAL)
07/14/2023
07/21/2023
IV
185mg
Q8hours
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: